SynthesisPeerJ2026
Seroprevalence of toxoplasmosis, rubella, cytomegalovirus, herpes simplex, and syphilis infections among pregnant women and infants in Malaysia: a systematic review and meta-analysis.
Synthesis in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Toxoplasmosis, rubella, cytomegalovirus, herpes simplex, and syphilis (TORCH) infections in infants and pregnant women are a cause for concern. However, the true prevalence of the infections among these populations in Malaysia is unknown. Methodology: This study represents the first systematic review and meta-analysis to assess the seroprevalence of TORCH agents in pregnant women and infants in Malaysia. Data from scientific articles published until November 2025 were analyzed. Results: A total of 19 reports on the seroprevalence of infection by TORCH agents in Malaysia were analyzed. The overall seroprevalence was 32.5% (95% CI [16.6-53.8%]; Conclusions: This study reveals a high seroprevalence of TORCH infection and underscores the importance of adequately screening pregnant women to prevent potential vertical transmission to the neonate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.